 |
|
|
| |
Seven Years of Treatment With Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection Is Safe and Well Tolerated and Associated With Sustained Virological, Biochemical, and Serological Responses With No Detectable Resistance
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Patrick Marcellin,1 Edward Gane,2 Naoky Tsai,3 Robert Flisiak,4 Jörg Petersen,5 Selim Gurel,6 Iskren A. Kotzev,7 Raul Aguilar Schall,8 John F. Flaherty,8 Anuj Gaggar,8 Kathryn M. Kitrinos,8 G. Mani Subramanian,8 John G. McHutchison,8 Jacob George,9 Maria Buti10
1Hôpital Beaujon, Clichy, France; 2Auckland City Hospital, Auckland, New Zealand; 3University of Hawaii at Manoa, Honolulu, HI; 4Medical University of Bialystok, Bialystok, Poland; 5University of Hamburg, Hamburg, Germany; 6Uludag Universitesi Tip Fakultesi, Bursa, Gorukle, Turkey; 7University Hospital Sveta Marina, Varna, Bulgaria; 8Gilead Sciences, Inc., Foster City, CA; 9Storr Liver Unit, Westmead Hospital, Sydney, New South Wales, Australia; 10Hospital General Universitari Vall d'Hebron and Networked Biomedical Research Center: Hepatic and Digestive Diseases (CIBERehd), Barcelona, Spain
|
| |
|
|
|
|
|
